FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Ascend Laboratories Fosfomycin Tromethamine Granules for Oral Recall

Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomyci…

Ascend Laboratories, LLC · Parsippany, NJ

Risk level
Class II
Reported by FDA
Feb 28, 2024
Recall ID
D-0339-2024
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Fosfomycin Tromethamine Granules for Oral starting Jan 16, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0339-2024 on Feb 28, 2024. Reason: Failed Impurities/Degradation Specification: Out of specification for organic impurities. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specification: Out of specification for organic impurities

Product description

Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomycin), single-dose sachet, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC. Parsippany, NJ 07054. NDC 67877-749-57

Lot numbers, UPCs & expiration codes

lOTS #: 22121458, 22121459, 22121460, 22121461, 22121462, 22121463, 22121464, Exp 4/2024; 22121176, 22121407, 22121465, Exp 3/2024; 22121761, 22121762, 22121763, 22121764, 22121766, 22121968, 22121969, Exp 5/2024.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0339-2024
Classification
Class II
Status
Ongoing
Recall initiated
Jan 16, 2024
FDA report date
Feb 28, 2024
Quantity
71,244 sachets
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories, LLC

Original FDA data

Every field from FDA enforcement report D-0339-2024, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Ongoing
Country
United States
Event ID
93816
Address
339 Jefferson Rd Ste 101
Code information
lOTS #: 22121458, 22121459, 22121460, 22121461, 22121462, 22121463, 22121464, Exp 4/2024; 22121176, 22121407, 22121465, Exp 3/2024; 22121761, 22121762, 22121763, 22121764, 22121766, 22121968, 22121969, Exp 5/2024.
Postal code
07054-3707
Report date
Feb 28, 2024
Product type
Drugs
Recall number
D-0339-2024
Classification
Class II
Recalling firm
Ascend Laboratories, LLC
Product quantity
71,244 sachets
Reason for recall
Failed Impurities/Degradation Specification: Out of specification for organic impurities
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomycin), single-dose sachet, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC. Parsippany, NJ 07054. NDC 67877-749-57
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 16, 2024
Initial firm notification
Letter
Center classification date
Feb 20, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0339-2024, published Feb 28, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls